Serum Institute Of India Profile
Key Indicators
- Authorised Capital ₹ 55.00 Cr
- Paid Up Capital ₹ 4.82 Cr
- Company Age 40 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
- Satisfied Charges ₹ 1,574.36 Cr
- Revenue Growth 3.20%
- Profit Growth 2.17%
- Ebitda -19.79%
- Net Worth 11.61%
- Total Assets 11.50%
About Serum Institute Of India
Serum Institute Of India Private Limited (SIOIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 May 1984 and has a history of 40 years and nine months. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Serum Institute Of India Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 55.00 Cr and a paid-up capital of Rs 4.82 Cr.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹1,574.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Serum Institute Of India Private Limited India are Sunder Kavitkar as COMPANY SECRETARY and Adar Poonawalla as Ceo. Cyrus Poonawalla, Zavareh Poonawalla, Adar Poonawalla, and Eight other members serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U80903PN1984PTC032945
- Company No.
032945
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 1984
- Date of AGM
26 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Serum Institute Of India Private Limited offer?
Serum Institute Of India Private Limited offers a wide range of products and services, including Metal, Security & Safety Detectors, Metal Detector, Sexual Wellness, Sexual Health Supplements, Health Conditions, Bone, Joint & Muscle Care.
Who are the key members and board of directors at Serum Institute Of India?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Cyrus Poonawalla  | Managing Director | 01-Jul-2007 | Current |
| Sunder Kavitkar | Company Secretary | 22-Apr-2023 | Current |
| Adar Poonawalla | CEO | 01-Apr-2008 | Current |
Board Members (10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Gairola | Whole-Time Director | 24-Aug-2021 | Current |
| Prasad Kulkarni | Whole-Time Director | 24-Aug-2021 | Current |
| Adar Poonawalla | Whole-Time Director and Ceo | 01-Apr-2008 | Current |
| Zavareh Poonawalla | Director | 22-May-1984 | Current |
| Behroze Poonawalla | Director | 01-Feb-1986 | Current |
| Umesh Shaligram | Whole-Time Director | 24-Aug-2021 | Current |
Financial Performance of Serum Institute Of India.
Serum Institute Of India Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.2% increase. The company also saw a slight improvement in profitability, with a 2.17% increase in profit. The company's net worth Soared by an impressive increase of 11.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serum Institute Of India?
In 2024, Serum Institute Of India had a promoter holding of 67.33% and a public holding of 32.67%. The company had 6 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sovereign Pharma Private LimitedCyrus Poonawalla and Adar Poonawalla are mutual person
Poonawalla Credit Private LimitedAdar Poonawalla is a mutual person
Poonawalla Fincorp LimitedAdar Poonawalla is a mutual person
Poonawalla Aviation Private LimitedCyrus Poonawalla is a mutual person
Poonawalla Estates Stud And Agri Farm Privae LimitedCyrus Poonawalla and Adar Poonawalla are mutual person
- Poonawalla Mystical Stud Private Limited
Zavareh Poonawalla and Behroze Poonawalla are mutual person
Charges (Loans)
₹10.00 Cr
₹1,574.36 Cr
Charges Breakdown by Lending Institutions
- Others : 10.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2021 | Others | ₹10.00 Cr | Open |
| 28 Jan 2021 | Others | ₹10.00 Cr | Satisfied |
| 28 Jan 2021 | Others | ₹10.00 Cr | Satisfied |
| 28 Jan 2021 | Others | ₹10.00 Cr | Satisfied |
| 10 Dec 2020 | Others | ₹10.00 Cr | Satisfied |
How Many Employees Work at Serum Institute Of India?
Serum Institute Of India has a workforce of 5876 employees as of Nov 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serum Institute Of India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serum Institute Of India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
